Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Daniel Shao-Weng Tan
Introduction
Daniel Shao-Weng Tan is a prominent inventor based in Singapore, known for his significant contributions to the field of cancer treatment. His innovative approach focuses on the use of biomarkers to predict a patient's susceptibility to anti-cancer drugs. This groundbreaking work has the potential to enhance personalized medicine and improve treatment outcomes for cancer patients.
Latest Patents
Daniel Tan holds a patent titled "Use of biomarkers in determining susceptibility to disease treatment." This invention outlines a method for predicting the susceptibility of cancer patients to anti-cancer drugs by detecting genetic alterations in long non-coding RNA (IncRNA) associated with oncogenes. Specifically, the patent highlights a silent G>A mutation at Q787Q of the epidermal growth factor receptor (EGFR) oncogene, which can indicate a patient's increased susceptibility to treatment. This innovative method not only aids in predicting treatment responses but also provides a framework for developing targeted therapies.
Career Highlights
Daniel Tan is affiliated with Singapore Health Services Pte Ltd, where he continues to advance research in cancer treatment. His work emphasizes the importance of genetic factors in determining the effectiveness of therapies, paving the way for more personalized approaches in oncology. His dedication to improving patient care through innovative research has made him a valuable asset in the medical community.
Collaborations
Daniel Tan collaborates with Narayanan Gopalakrishna Iyer, working together to explore new avenues in cancer research and treatment. Their partnership exemplifies the collaborative spirit necessary for advancing medical science and improving patient outcomes.
Conclusion
Daniel Shao-Weng Tan's contributions to cancer treatment through his innovative patent and collaborative efforts highlight the importance of personalized medicine in oncology. His work continues to inspire advancements in the field, ultimately aiming to improve the lives of cancer patients.